Skip to the main content.

1 min read

Alcami Appoints Chief Manufacturing Officer

Alcami Corporation today announced the appointment of Jamie Iudica to Chief Manufacturing Officer.  

Wilmington, North Carolina – March 9, 2023 – Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the appointment of Jamie Iudica to Chief Manufacturing Officer.  

Jamie brings more than 25 years of experience in the pharmaceutical industry, including leadership roles in engineering, manufacturing, and supply chain operations. Prior to joining Alcami, Jamie was Chief Manufacturing Officer at Istari Oncology. He has served multiple manufacturing and operations leadership roles throughout his career including executive roles at Xellia Pharmaceuticals, Pfizer, and Hospira.  

“Jamie’s extensive expertise in drug product manufacturing operations will be integral as we expand the Alcami manufacturing and operations footprint,” commented Patrick Walsh, Chairman and Chief Executive Officer at Alcami Corporation.

After an exceptional 40-year career spanning all facets of the pharmaceutical industry, Alcami Chief Operations Officer Ken Domagalski has announced his intention to retire later this year. Ken has been instrumental in the design and build out of Alcami’s sterile manufacturing facilities and played a critical role in the growth of the company. He has led numerous successful FDA and international regulatory inspections over the course of his career, managed pharmaceutical organizations around the globe, and the Alcami team has been honored to work alongside Ken.
“We are thankful for the service and leadership Ken has provided during his tenure with Alcami and wish him the best as he transitions to retirement,” commented Patrick.

As Chief Manufacturing Officer, Jamie will assume Ken’s responsibilities for Alcami's extensive drug product manufacturing operations that provide clinical to commercial sterile and oral solid dose development and manufacturing services. Jamie holds both a B.A. in Chemical Engineering and an MBA from Villanova University in Villanova, PA.


11 min read

Alcami Supporting Potential COVID-19 Treatment

WOODCLIFF LAKE, N.J. —April 16, 2020— Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”), a New Jersey-based pharmaceutical company, today...

Read More

5 min read

PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products

Leading U.S.-based CDMO to manufacture PharmaTher’s proprietary ketamine products for FDA Phase 3 clinical studies and global commercialization.

Read More

1 min read


Read More